Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma

Summary

Chiauranib, which simultaneously targets against VEGFR/Aurora B/CSF-1R, several key kinases involved in tumor angiogenesis, tumor cell mitosis, and chronic inflammatory microenvironment.

Timeline

Start

2018-04-28

Primary completion

2019-11-01

Completion

2019-11-01

Drugs

Indications